Advertisement

Topics

Companies Related to "Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients" [Most Relevant Company Matches] RSS

16:31 EDT 21st May 2018 | BioPortfolio

Here are the most relevant search results for "Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients" found in our extensive corporate database of over 50,000 company records.

Showing "Endovascular Exclusion Abdominal Aortic Aneurysms High Risk Patients" Companies 1–25 of 8,000+

Extremely Relevant

Endospan

Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. Endospan has initiated the CE-marking regulatory process to market in Europe the NEXUS™ Stent Graft System, the first endovascular off-the-shelf system to treat Aortic Arch Dise...


Aptus Endosystems, Inc

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002, Aptus Endosystems has developed a unique endograft and endovascular stapling system that provides a durable alternative to open surgical repair by separating the functions of ane...

Aptus Endosystems, Inc.

Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002, Aptus Endosystems has developed a unique endograft and endovascular stapling system delivered via standard catheter technology. The technology allows surgeons to treat abdominal ...


Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enl...

Find the AAAnswers Coalition

The Find the AAAnswers Coalition is an alliance of medical societies that have come together to provide accurate information about abdominal aortic aneurysms (AAA) and increase the number of at-risk individuals that get screened. Coalition partners include:

Neural Intervention Technologies, Inc.

Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that result in hemorrhagic stroke.NIT is developing ALGEL™-I and -II, novel embolic materials, into minimally invasive treatments for cerebral arteriovenous malformations and aneurysms. In addition, NIT w...

Lombard Medical Technologies PLC

Lombard Medical Technologies PLC is a global medical technology company focussed on providing innovative endovascular products which broaden clinicians’ treatment options and opportunities for treating more patients safely and more efficiently with Endovascular Aortic Repair (EVAR). Aorfix™ endovascular stent graft, Lombard Medical Technologies flagship product, addresses previousl...

Cardiatis S.A.

Cardiatis is a commercial stage medical technology company developing disease modifying endovascular solutions to thoracoabdominal aneurysms. Cardiatis lead product is the Cardiatis C5, a second generation multilayer flow modulating device indicated for true degenerative Crawford V thoracoabdominal aneurysms with diameters in the 5.5- to 7-cm range.

Relevant

Thubrikar Aortic Valve, Inc.

Thubrikar Aortic Valve, Inc., founded in October 2010, is a privately held medical device company headquartered in Norristown, PA. The Company has developed a low-profile, bovine pericardial, self-expanding percutaneous valve for transcatheter aortic valve implantation (TAVI) - called the “Optimum TAV” - as a treatment option for aortic stenosis. ...

BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling...

Lombard Medical, Inc.

Lombard Medical, Inc. will become the parent company of Lombard Medical Technologies PLC (“LMT”), a medical device company focused on device solutions for the $1.4 billion per annum abdominal aortic aneurysm repair market following a court approved scheme of arrangement. LMT’s lead product, Aorfix™, is an endovascular stent graft which has bee...

Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it ...

AspenBio Pharma, Inc.

AspenBio Pharma, Inc. is an emerging in vitro diagnostic company focused on obtaining FDA clearance for its lead product, AppyScore, which is a unique blood-based test in development designed to help physicians manage the large number of patients who enter emergency rooms every year complaining of abdominal pain, many suspected of having acute appendicitis...

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

Micrus Endovascular

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain re...

The Lisa Colagrossi Foundation

The Lisa Colagrossi Foundation (TLCF) is the leader in raising awareness and education to help diagnose and treat brain aneurysms. TLCF's primary focus is to communicate the signs, symptoms and risk factors of brain aneurysms through innovation and collaboration with best in class partners in the U.S. and internationally. In the process, we are shedding...

NeuroVasx, Inc.

To develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and therapeutic devices for the neurovascular embolization market. Utilizing unique materials, NeuroVasx's products are intended for the treatment of intracranial aneurysms that, because of their morphol...

JenaValve Technology, Inc.

JenaValve Technology, Inc., a U.S. corporation with primary operations in Munich, Germany, develops, manufactures and markets transcatheter aortic valve implantation systems (TAVI) to treat patients suffering from aortic valve disease. JenaValve was founded in 2006 by cardiologists and inventor’s Prof. Hans R. Figulla, M.D. and Prof. Markus Ferrari, M...

Metactive Medical, Inc.

Metactive is developing novel endovascular medical devices for the treatment of neurovascular and peripheral vascular diseases. Metactive's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. For more information, please visit www.metactivemed...

Nfocus Neuromedical Inc.

Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier venture investors, the Company is developing revolutionary systems to treat neurovascular disease - including brain aneurysms - which are simple, safe, cost-effective and curative.

Aortica Corporation

Aortica Corporation was founded to design, manufacture, and market tools for treatment of patients with AAA disease who have aortic anatomy that limits their treatment options. While EVAR has become the gold standard for treatment of AAA disease, between 30-40% of patients are not candidates for EVAR because their aortic anatomy is structured in a manner t...

Astute Medical, Inc.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. The Company's current areas of interest include abdominal ...

MAQUET Cardiovascular LLC

Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a balance of open and endovascular therapies depending on the patient's needs and condition. Traditional open vascular interventions are often used to repair ruptured, occluded or atypical vessels that ...

JenaValve Technology GmbH

JenaValve Technology is a medical device company focused on developing transcatheter-delivered aortic valve systems to treat patients suffering from aortic valve disease. The company develops replacement aortic valve systems for both transapical and transfemoral approaches (TAVI) to address the needs of cardiac surgeons and cardiologists. JenaValve is back...

Three Rivers Medical, Inc.

Three Rivers Medical, Inc. is a privately held medical device company focused on expanding the endovascular management of cerebral aneurysms and stroke. The company manufactures the Rio Embolization Coil System in Mountain View, CA. The Rio Embolization Coil System is not approved for sale in the United States.


More From BioPortfolio on "Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks